Sensus Healthcare Sues Skincure Oncology for Millions in Unpaid Medical Equipment
SRTS sits 32% above its 52-week low of $3.03 on light trading volume (0.2× avg).
Summary
Sensus Healthcare has initiated a lawsuit against Skincure Oncology, alleging a breach of contract and seeking to recover millions of dollars for medical equipment that Skincure has used since August 2025 but is now refusing to fully pay for. This legal action is highly material for Sensus Healthcare, which recently reported a challenging 2025 with a 34% revenue decrease and a $7.7 million net loss, in addition to defaulting on a credit facility profitability covenant. The potential recovery of millions of dollars could significantly impact the company's financial position and liquidity, addressing a portion of its recent revenue struggles. Traders will closely watch the litigation's progress and outcome, as it represents a significant potential cash inflow or, conversely, a source of ongoing legal expenses and uncertainty.
At the time of this announcement, SRTS was trading at $4.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $66M. The 52-week trading range was $3.03 to $5.92. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Reuters.